or
forgot password

    • cancer clinical trials in sedona, AZ

    • PhII ICb With/Without Erbitux in MBC Pts
    Northern AZ Hematology & Oncology Assoc
    Sedona, Arizona 86336
    Metastatic Breast Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Northern AZ Hematology & Oncology Associates
    Sedona, Arizona 86336
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Northern AZ Hematology Oncology Associates-AOA
    Sedona, Arizona 86336
    Breast Cancer
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    Northern AZ Hematology & Oncology Assoc
    Sedona, Arizona 86336
    Androgen-independent Prostate Cancer
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    Northern Arizona Hematology and Oncology Associates-AOA
    Sedona, Arizona 86336
    Metastatic Pancreatic Cancer
    A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
    Location #12
    Sedona, Arizona 86336
    Metastatic Breast Cancer
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Arizona Oncology Associates, PC - NAHOA
    Sedona, Arizona 86336
    Metastatic Breast Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Arizona Oncology Associates, PC - NAHOA
    Sedona, Arizona 86336
    Chronic Myeloid Leukemia
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Arizona Oncology Associates, PC - NAHOA
    Sedona, Arizona 86336
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    Northern AZ Hematology & Oncology Assoc.
    Sedona, Arizona 86336
    Prostate Cancer, Hormone Refractory Prostate Cancer
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Northern Arizona Hematology & Oncology Associates
    Sedona, Arizona 86336
    Non-Small Cell Lung Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Northern Arizona Hematology & Oncology Associates
    Sedona, Arizona 86336
    Carcinoma, Non-Small-Cell Lung
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Northern AZ Hematology & Oncology Assoc
    Sedona, Arizona 86336
    Colorectal Cancer Metastatic
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Northern Arizona Hematology & Oncology Associates
    Sedona, Arizona 86336
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
    Northern Arizona Hematology & Oncology Associates, AOA
    Sedona, Arizona 86336
    Prostate Cancer
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Northern AZ Hematology & Oncology Associates-Sedona
    Sedona, Arizona 86336
    Metastatic Breast Cancer
    Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
    Northern Arizona Hematology & Oncology Associates
    Sedona, Arizona 86336
    Metastatic Breast Cancer
    Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy
    Northern Arizona Hematology & Oncology Associates
    Sedona, Arizona 86336
    Ovarian Cancer